Earnings call transcript: R. Stahl AG Q4 2025 reports stable EBITDA amid challenges

R. Stahl AG reported Q4/FY2025 revenue of EUR 330 million, down roughly 9%-10% year over year, while EBITDA held flat at EUR 34 million and the margin stayed at 11%. Net profit fell to EUR 3 million and free cash flow broke even, versus more than EUR 50 million last year, pushing net debt up by EUR 35 million. Management issued 2026 guidance for EUR 285 million-EUR 300 million of sales and outlined the NEXUS restructuring and transformation program aimed at improving margins, cash flow, and international scale.

Analysis

The setup is less about one quarter’s earnings and more about a widening strategic bifurcation: the company is defending margin through cost actions while intentionally sacrificing near-term cash generation to fund a repositioning toward higher-value, more solution-heavy offerings. That usually benefits larger, better-capitalized competitors in the interim, because customers and channel partners tend to defer new platform decisions until the incumbent can prove delivery quality and service continuity. The first-order loser is working-capital efficiency; the second-order loser is any supplier ecosystem that depended on the old, more commoditized product mix and a faster replenishment cycle.

The key hidden risk is that the transformation is being launched from a weak balance-sheet posture, which makes execution path-dependent. If the expected cost takeout slips by even two quarters, the company will likely need to choose between deeper restructuring, external capital, or slower international buildout; all three would depress the equity multiple. Conversely, if the operating reset is real, the earnings inflection should show up first in 2H26 via lower personnel drag and improved cash conversion, with the market likely re-rating before revenue growth visibly returns.

The contrarian read is that the market may be underestimating how much of the current valuation already embeds a “no-growth” outcome. That creates asymmetric upside if management can credibly demonstrate that free cash flow normalizes without incremental dilution. The challenge is that the gap between strategy and monetization is wide: the next 6-12 months are about proving governance, cost flexibility, and customer retention—not about selling the 2030 vision. Until then, this remains a classic execution story where the stock can work on credibility gains even before fundamentals fully improve.

Key Decisions for Investors

• Avoid chasing the equity on the strategic reset alone; wait for 2H26 evidence that working capital and personnel costs are trending down before establishing a long. Best entry is on a post-announcement pullback if management guides to visible 2026 FCF improvement.
• If you want exposure, prefer a limited-risk upside structure: buy 6-12 month call spreads instead of outright stock. The trade works if the market starts pricing a balance-sheet stabilization and avoids dilution; it fails if funding risk re-enters.
• Pair trade idea: long higher-quality industrial automation/controls names with stronger cash generation against a short in the weaker transformation story. The thesis is that solution-led industrials with strong FCF will re-rate relative to names still digesting restructuring costs.
• For a tactical short, use a 3-6 month horizon only if there is evidence of delayed cost actions or weaker order intake. The risk is a sharp short-covering rally if management delivers even modest credibility on 2026 cash flow.